Your Input: | |||||
PDCD5 | Programmed cell death 5. (145 aa) | ||||
MLLT11 | MLLT11 transcription factor 7 cofactor. (89 aa) | ||||
ENSGAGP00000035185 | Uncharacterized protein. (54 aa) | ||||
BAK1 | BCL2 antagonist/killer 1. (211 aa) | ||||
ENSGAGP00000026310 | Uncharacterized protein. (141 aa) | ||||
FAM162A | Family with sequence similarity 162 member A. (140 aa) | ||||
BNIP3 | BCL2 interacting protein 3. (205 aa) | ||||
ENSGAGP00000036275 | Uncharacterized protein; Belongs to the TRAFAC class dynamin-like GTPase superfamily. Dynamin/Fzo/YdjA family. (705 aa) | ||||
ENSGAGP00000000264 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. (188 aa) | ||||
ENSGAGP00000000636 | Uncharacterized protein. (332 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (446 aa) | ||||
MMP9 | Matrix metallopeptidase 9. (710 aa) | ||||
CIDEB | Cell death inducing DFFA like effector b. (215 aa) | ||||
BMF | Bcl2 modifying factor. (192 aa) | ||||
PINK1 | PTEN induced kinase 1. (500 aa) | ||||
HRK | Harakiri, BCL2 interacting protein. (87 aa) | ||||
DNM1L | Dynamin 1 like; Belongs to the TRAFAC class dynamin-like GTPase superfamily. Dynamin/Fzo/YdjA family. (735 aa) | ||||
GPER1 | G protein-coupled estrogen receptor 1; Belongs to the G-protein coupled receptor 1 family. (358 aa) | ||||
PLA2G6 | Phospholipase A2 group VI. (804 aa) |